Diabetes
News
FDA issues warning about use of unauthorized diabetes devices
The agency received an adverse event report about a patient using a combination of unauthorized devices who required medical intervention.
Conference Coverage
Type 2 diabetes remission: Reducing excess fat in the liver might be the key
LOS ANGELES – ...
Conference Coverage
Canagliflozin after metabolic surgery may aid weight loss, reduce glucose levels
LOS ANGELES – Reductions in adiponectin, leptin, and high–molecular weight adiponectin did not reach statistical significance.
Conference Coverage
Mystery hypoglycemia case highlights troublesome diagnosis
LOS ANGELES – Nothing seemed to help a 69-year-old female patient, until an alert nurse noticed something important...
Conference Coverage
SGLT2 inhibitors prevent HF hospitalization regardless of baseline LVEF
NEW ORLEANS – “At least in my mind, we have more than enough evidence at this point to say that SGLT2 inhibitors are effective in preventing heart...
Conference Coverage
Short-term use of CGMs can deliver life-changing data for patients with type 2 diabetes
LOS ANGELES –
Video
AACE 2019: Top takeaways from Yehuda Handelsman and Paul Jellinger
LOS ANGELES – Yehuda Handelsman, MD, and Paul S. Jellinger, MD, summarized some of the key takeaways from this year’...
News
FDA approves Qternmet XR as adjunct therapy for glycemic improvement in type 2 diabetes
FDA approval is based on results from a pair of phase 3 trials that tested different combinations of dapagliflozin and saxagliptin.
From the Journals
Fournier gangrene cases surge in patients using SGLT2 inhibitors
Serious complications and death are likely if Fournier gangrene is not recognized.
Latest News
Weight-loss drug options expand, but beware cardiac risk
LOS ANGELES – Even diabetes drugs can help patients shed pounds, but more powerful alternatives are available.
Video
New adventures of an old device: Clinic delivers cortisol via the insulin pump
LOS ANGELES – The pump may be a solution for patients with adrenal insufficiency who fare poorly on pills.